Study Validating MoA of Intranasal Foralumab in Alzheimer’s Disease Published in the Prestigious Journal PNAS, Following FDA IND Clearance
September 06, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”FDA has cleared the IND for intranasal...
Tiziana Life Sciences Announces Live Bloomberg TV Interview of Renowned Scientist Dr. Howard L. Weiner to Discuss FDA IND Clearance for Intranasal Foralumab in Alzheimer's Disease
August 17, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
NFI Group Inc. announces delivery of the 1,500th electric bus from the BYD–Alexander Dennis partnership
August 08, 2023 07:30 ET
|
NFI Group Inc
LARBERT, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a leader...
Team One Announces New Leadership for Dallas Office
August 03, 2023 09:45 ET
|
Team One
Team One Appoints Next Generation Leaders; Putting Creativity and Collaboration on A Pedestal with Organizational Moves. LOS ANGELES, Aug. 03, 2023 (GLOBE NEWSWIRE) -- As an agency that began as a...
Pfizer’s Litfulo Poised to Follow Similar Trajectory as Eli Lilly/Incyte’s Olumiant for the Treatment of Severe Alopecia Areata
July 11, 2023 09:58 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 11, 2023 (GLOBE NEWSWIRE) -- In June 2022, Eli Lilly and Incyte’s Olumiant became the first and only approved advanced systemic treatment for adults with severe alopecia...
NFI announces additional order from Go-Ahead London for 141 electric buses from the BYD–Alexander Dennis partnership
July 06, 2023 08:16 ET
|
NFI Group Inc
LARBERT, United Kingdom, July 06, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach manufacturer and a...
Tiziana Life Sciences to File Alzheimer’s IND for Intranasal Foralumab in Q2 2023
April 20, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
Application for $3M of non-dilutive funding for Phase 2a Alzheimer’s trial will be submitted in Q2 2023Tiziana guided by FDA Type “B” meeting comments on its scheduled Q2 2023 intranasal foralumab...
NFI subsidiary Alexander Dennis receives repeat electric bus order from National Express West Midlands for 170 double deck buses
April 13, 2023 08:00 ET
|
NFI Group Inc
LARBERT, Scotland and IVER, United Kingdom, April 13, 2023 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the “Company”), a leading independent bus and coach...
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Disorders Conference in Sweden
March 31, 2023 07:00 ET
|
Tiziana Life Sciences Ltd.
Data shows reduction of microglia activation and improvement in behavior in rodent model of Alzheimer’s disease (AD)Modulation of neuroinflammation may be synergistic to existing treatments in AD NEW...
PlayMining GameFi Platform Unveils Revolutionary “Product Placement NFT” Advertising Solution
March 14, 2023 03:30 ET
|
PlayMining
SINGAPORE, March 14, 2023 (GLOBE NEWSWIRE) -- Digital Entertainment Asset (DEA), a Singapore-based global Web3 entertainment company, has launched ‘Product Placement NFTs’ as a new advertising...